Nick Enslin, Chief Technology Officer, Immobazyme, joins a formidable line-up of speakers for the 2023 International Longevity Summit.
The International Longevity Summit provides relevant insights into the longevity subject, expert education, investment opportunities, excellent networking opportunities, and a great setting in an exclusive location. The two-full-day conference is bringing together the world’s top longevity Key Opinion Leaders (KOLs), Institutional and Private investors, Wealthy private investors, Families, Offices, and Funds.
Nick Enslin Speaker Profile: Part 12
Nick Enslin is CTO, Co-Founder of Immobazyme. Immobazyme is a biotech spin-out company from Stellenbosch University that is revolutionizing the production of high-value active protein ingredients through precision fermentation.
The discussion of Immobazyme began as a company that would leverage innovative technologies and environmentally responsible practices to drive sustainable growth in scientific research and development in South Africa.
This concept quickly evolved into a thriving start-up focused on bringing cutting-edge biologics to markets that were previously constrained by cost or implementation challenges. Today, the company has expanded significantly from its founding team of three master’s candidates to a team of seven highly skilled and experienced scientists, all of whom are committed to catalyzing the future of global innovation through precision fermentation.
Nick Enslin has an MSc in Biotechnology from the Institute of Plant Biotechnology at Stellenbosch University.
To find out more about the International Longevity Summit and how to register, click HERE.
For more links to content on the ILS program
Longevity has featured several posts on the International Longevity Summit. You can read more about the conference and speakers here.